JMP Securities Reaffirms Their Buy Rating on Clearside Biomedical (CLSD)
October 12 2022 - 02:15AM
TipRanks
JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on
Clearside Biomedical (CLSD - Research Report) today and set a price
target of $7.00. The company's shares closed yesterday at
$1.16.According to TipRanks, Wolleben is an analyst with an average
return of -12.3% and a 28.06% success rate. Wolleben covers the
Healthcare sector, focusing on stocks such as Altimmune, Madrigal
Pharmaceuticals, and Intercept Pharma.Clearside Biomedical has an
analyst consensus of Strong Buy, with a price target consensus of
$7.00.
https://www.tipranks.com/news/blurbs/jmp-securities-reaffirms-their-buy-rating-on-clearside-biomedical-clsd?utm_source=advfn.com&utm_medium=referral
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Mar 2023 to Mar 2023
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Mar 2022 to Mar 2023
